ARCHIVES

Revlimid Maintenance Therapy Delayed Progression by 90%

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

New Approaches To Improve Diagnoses In Urogenital Cancers Presented At AUA

September 24, 2004

Holden Center At U. Of Iowa Designated Comprehensive.

January 26, 2001

In Brief: Revlon Foundation Gives $7.5 Million To UCA for Women’s Health Research, Breast Cancer

December 16, 1994

ASCO Highlights Six Studies From Meeting To Showcase Advances In Cancer Care

May 30, 2008

FDA, NCI Near Agreement On Handling INDs

January 28, 1977

More Than 300 request RFP for New Community Oncology Program

May 25, 1979